# Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

> **NCT00593606** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 124 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine

## Key facts

- **NCT ID:** NCT00593606
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2014-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593606, "Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00593606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*